NCT02189304View on ClinicalTrials.gov

Pharmacokinetics and Safety Study of PT010 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 1, 2014

Primary Completion Date

September 1, 2014

Study Completion Date

September 1, 2014

Conditions
COPD
Interventions
DRUG

PT010

PT010; Budesonide, Glycopyrrolate, and Formoterol Fumarate Inhalation Aerosol. Administered as 2 inhalations

DRUG

PT009

PT009 administered as 2 inhalations

DRUG

Symbicort Turbohaler

Symbicort Turbohaler taken as 2 inhalations

Trial Locations (1)

21201

SNBL Clinical Pharmacology Center, Baltimore

Sponsors
All Listed Sponsors
lead

Pearl Therapeutics, Inc.

INDUSTRY